Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 17, 2006, Pages 6106-6119

  Huang, Shu Ting ^a   Hsei, I Jen ^b   Chen, Chinpiao ^a  

^a NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Anticancer; Benzothiazole; Bis(benzoxazole); Cytotoxicity

Indexed keywords

2 (2 BENZYLOXYPHENYL) 1H BENZOIMIDAZOLE 4 CARBOXYLIC ACID; 2 (2 BENZYLOXYPHENYL) 1H BENZOIMIDAZOLE 4 CARBOXYLIC ACID METHYL ESTER; 2 (2 BENZYLOXYPHENYL)BENZOXAZOLE 4 CARBOXYLIC ACID; 2 (2 BENZYLOXYPHENYL)BENZOXAZOLE 4 CARBOXYLIC ACID METHYL ESTER; 2 (2 HYDROXYPHENYL) 1H BENZOIMIDAZOLE 4 CARBOXYLIC ACID; 2 (2 HYDROXYPHENYL) 1H BENZOIMIDAZOLE 4 CARBOXYLIC ACID METHYL ESTER; 2 (2 HYDROXYPHENYL)BENZOTHIAZOLE 4 CARBOXYLIC ACID METHYL ESTER; 2 (2 HYDROXYPHENYL)BENZOXAZOLE 4 CARBOXYLIC ACID METHYL ESTER; 2 (2 HYDROXYPHENYL)BENZOXAZOLE 7 CARBOXYLIC ACID METHYL ESTER; 2 (2 METHOXYPHENYL)BENZOXAZOLE 7 CARBOXYLIC ACID; 2 (2 METHOXYPHENYL)BENZOXAZOLE 7 CARBOXYLIC ACID METHYL ESTER; 2 [[2 (BENZYLOXYPHENYL)BENZOTHIAZOLE 4 CARBONYL]AMINO]BENZOIC ACID METHYL ESTER; 2 [[2 (BENZYLOXYPHENYL)BENZOXAZOLE 4 CARBONYL]AMINO] 3 HYDROXY BENZOIC ACID METHYL ESTER; 2 AMINO 3 [[2 (2 BENZYLOXYPHENYL) 1H BENZOIMIDAZOLE 4 CARBONYL]AMINO] BENZOIC ACID METHYL ESTER; 2' (2 BEZYLOXYPHENYL) 1H,1'H [2,4']BIBENZOIMIDAZOLYL 4 CARBOXYLIC ACID; 2' (2 BEZYLOXYPHENYL) 1H,1'H [2,4']BIBENZOIMIDAZOLYL 4 CARBOXYLIC ACID METHYL ESTER; 2' (2 HYDROXYPHENYL) 1H,1'H [2,4']BIBENZOIMIDAZOLYL 4 CARBOXYLIC ACID METHYL ESTER; 2' (2 HYDROXYPHENYL) [2,4']BIBENZOXAZOLYL 4 CARBOXYLIC ACID METHYL ESTER; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; UK 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IC 50;

BENZIMIDAZOLES; BENZOTHIAZOLES; BENZOXAZOLES; CELL LINE, TUMOR; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 33746077081     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.05.007     Document Type: Article

References (18)

1. Ueki M., Ueno K., Miyadoh S., Abe K., Shibata K., Taniguchi M., and Oi S. J. Antibiot. 46 (1993) 1089
2. Ueki M., Shibata K., and Taniguchi M. J. Antibiot. 51 (1998) 883
3. Ueki M., and Taniguchi M. J. Antibiot. 50 (1997) 788
4. Sato S., Kajiura T., Noguchi M., Takehana K., Kobayasho T., and Tsuji T. J. Antibiot. 54 (2001) 102
5. Reynolds M.B., DeLuca M.R., and Kerwin S.M. Bioorg. Chem. 27 (1999) 326
6. Kumar D., Jacob M.R., Reynold M.B., and Kerwin S.M. Bioorg. Med. Chem. 10 (2002) 3994
7. Wang B.B., Maghami N., Goodlin V.L., and Smith P.J. Bioorg. Med. Chem. Lett. 14 (2004) 3221
8. DeLuca M.R., and Kerwin S.M. Tetrahedron Lett. 38 (1997) 199
9. Seno K., Hagishita S., Sato T., and Kuriyama K. J. Chem. Soc., Perkin Trans. 1 (1984) 2013
10. Castro-Palomino J.C., and Schmidt R.R. Tetrahedron Lett. 38 (1995) 6871
11. Astles P.C., Brown T.J., Handscombe C.M., Harper M.F., Harris N.V., Lewis R.A., Lockey P.M., Mccarthy C., Mclay I.M., Poter B., Roach A.G., Smith C., and Walsh R.J.A. Eur. J. Med. Chem. 32 (1997) 409
12. Kumar D., Jacob M.R., Reynolds M.B., and Kerwin S.M. Bioorg. Med. Chem. 10 (2002) 3997
13. Cohen S.M., Meyer M., and Raymond K.N. J. Am. Chem. Soc. 120 (1998) 6277
14. Shi D.-F., Bradshaw T.D., Wrigley S., McCall C.J., Lelieveld P., Fichtner I., and Stevens M.F.G. J. Med. Chem. 39 (1996) 3375
15. Das J., Lin J., Moquin R.V., Shen Z., Spergel S.H., Wityak J., Doweyko A.M., DeFex H.F., Fang Q., Pang S., Pitt S., Shen D.R., Schieven G.L., and Barrish J.C. Bioorg. Med. Chem. Lett. 13 (2003) 2145
16. Bakouche O., Mougin B., and Gerlier D. Immunology 62 (1987) 605
17. Reyzer M.L., Brodbelt J.S., Kerwin S.M., and Kumar D. Nucleic Acid Res. 29 (2001) e103
18. The steric energy was calculated using the MM2 program (CS Chem3D Pro).